Post-surgical pain control is often inadequate and opioid-dependent.
Opioid-based pain-relief drugs increase the risk of opioid abuse by 14x1.
Surgeons, patients, and public health authorities want a non-opioid drug that can:
- Lower post-operative pain
- Speed rehabilitation times
- Reduce post-operative visits
- Lower opioid use, side-effects, and risk of addiction
Surgeons, patients, and public health authorities want better, safer pain control.
BPI-004 (“Enduracaine”) is a non-opioid, single-dose injectable local analgesic that provides up to three days of pain relief following surgical procedures.
- Non-opioid
- Multi-day pain relief
- Low toxicity
- Low motor impairment
Oral & maxillofacial surgery, orthopedic surgery, general surgery, podiatric surgery, gynecological surgery, CT surgery
Seamless Product Integration
Exceptional products are convenient and seamless.
Enduracaine will be provided in 10ml pre-filled syringes (e.g. orthopedic surgery) and standard dental cartridges (e.g. oral surgery).
A post-surgical analgesic designed to meet all fundamental clinician needs
BPI-004 and BPI-005 are designed to be cost-effective and easy to administer:
- Supplied in pre-filled syringes (e.g. orthopedic surgery) or standard dental cartridges (oral surgery)
-
Require no additional steps, equipment, or training
- Economically priced
